Literature DB >> 6601497

In vitro properties of mixtures of fibrin seal and antibiotics.

H Redl, G Schlag, G Stanek, A Hirschl, T Seelich.   

Abstract

The incorporation of gentamycin, neomycin and Polymyxin E into fibrin seal results in prolonged clotting time after mixture with 4 NIH-units of thrombin per ml in vitro. The aminoglycoside antibiotics gentamycin and neomycin also diminished fibrin-alpha-chain crosslinkage and, as a consequence, clot rigidity, as demonstrated with clots containing gentamycin. Clotting time and the rate of alpha-chain crosslinking can be adjusted to normal values by the use of higher thrombin concentrations and incorporation of additional factor XIII into the sealing system. Drug release from the clots was similar for all three antibiotics tested and mainly dependent on the concentration gradient between the clot and its environment. Under the conditions of the present study, about 85% of the antibiotic content of fibrin seal clots were released within 72 h.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601497     DOI: 10.1016/0142-9612(83)90066-2

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  Use of fibrin sealants for the localized, controlled release of cefazolin.

Authors:  Stephen Tredwell; John K Jackson; Donald Hamilton; Vivian Lee; Helen M Burt
Journal:  Can J Surg       Date:  2006-10       Impact factor: 2.089

2.  The sustained release of antibiotic from freeze-dried fibrin-antibiotic compound and efficacies in a rat model of osteomyelitis.

Authors:  M Itokazu; K Yamamoto; W Y Yang; T Aoki; N Kato; K Watanabe
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

3.  Subverting bacterial resistance using high dose, low solubility antibiotics in fibrin.

Authors:  C J Woolverton; K Huebert; B Burkhart; M MacPhee
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

4.  Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin.

Authors:  Yaron S Brin; Jacob Golenser; Boaz Mizrahi; Guy Maoz; Abraham J Domb; Shyamal Peddada; Shmuel Tuvia; Abraham Nyska; Meir Nyska
Journal:  J Control Release       Date:  2008-07-20       Impact factor: 9.776

5.  Plasma Bead Entrapped Liposomes as a Potential Drug Delivery System to Combat Fungal Infections.

Authors:  Munazza Tamkeen Fatima; Zeyaul Islam; Ejaj Ahmad; Mehboob Hoque; Marriam Yamin
Journal:  Molecules       Date:  2022-02-07       Impact factor: 4.411

6.  Impact of local and systemic antimicrobials on leukocyte- and platelet rich fibrin: an in vitro study.

Authors:  S A M Siawasch; C Andrade; A B Castro; W Teughels; A Temmerman; M Quirynen
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

Review 7.  Fibrin as a Multipurpose Physiological Platform for Bone Tissue Engineering and Targeted Delivery of Bioactive Compounds.

Authors:  Bruno Bujoli; Jean-Claude Scimeca; Elise Verron
Journal:  Pharmaceutics       Date:  2019-10-28       Impact factor: 6.321

8.  A novel antimicrobial coating to prevent periprosthetic joint infection.

Authors:  Rita Ramalhete; Robyn Brown; Gordon Blunn; John Skinner; Melanie Coathup; Ian Graney; Anita Sanghani-Kerai
Journal:  Bone Joint Res       Date:  2020-12       Impact factor: 4.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.